CanReview Research Ethics Initiative Funding Opportunity

ResearchNet - RechercheNet

• Search Again

• Back to Results

• Print Preview Opens in a new window

• Watch this Opportunity

• Notify a Colleague

Funding Opportunity Details

Funding Organization Canadian Institutes of Health Research Program Name Other
:

Pan-Canadian Single Research Ethics Review Initiative (CanReview) Sponsor(s) The Canadian Institutes of Health Research (CIHR) Program Launch Date 2026-04-21

Important Dates

Competition	202606SRI
Application Deadline	2026-06-16
Anticipated Notice of Decision	2026-09-24
Funding Start Date	2026-10-01

---

Notices

Tri-agency CV

This funding opportunity uses the tri-agency CV. This narrative-style CV is more flexible and allows applicants to best highlight their wide range of outputs and expertise. The tri-agency CV allows applicants to capture relevant information, describe their career trajectories in more detail, provide indicators of quality and impact, and provide context to their contributions in a narrative format to help peer reviewers assess their track record. More information on the new CV is available on the tri-agency CV – frequently asked questions page.

As we gradually transition to the tri-agency CV, the system may continue to display references to the CCV. Please note that all participants must follow the tri-agency CV instructions as specified in the Funding Opportunity and complete and attach the tri-agency CV.

For details on using the tri-agency CV on this funding opportunity, see the section.

---

Table of Contents

-

-

-

-

---

Description

Background

Ethics review for multi-site, multi-jurisdictional clinical trials in Canada is often fragmented and uncoordinated, with significant variability and unpredictability in overall timelines. This can delay access to innovative medical interventions for patients and limit broad participant reach which can hinder the recruitment of diverse and representative trial populations. Extended start-up periods also increase costs and reduce efficient use of resources.

Research Ethics Board (REB) practices for Tri-Agency-funded human research in Canada are guided by the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS), which also provides principles for multi-jurisdictional research and describes alternative acceptable models of streamlined REB review. Despite this guidance, adoption of streamlined review models remains inconsistent, and many institutions still require separate reviews, perpetuating variability and extended timelines. While some provinces and networks have adopted streamlined models, these solutions remain regional and do not constitute a pan-Canadian solution, which has long been called for by the clinical research community. A pan-Canadian solution is one that is national in scope and inclusive of all provinces and territories.

A pan-Canadian streamlined REB review process is critical to reduce duplication, improve coordination, enable faster and more consistent trial activation across the country, and maintain Canada’s competitiveness in clinical research. To address these challenges, CanReview, a collaborative initiative facilitated by Clinical Trials Ontario (CTO) and using the CTO Stream web-based platform, was launched in 2024 with time-limited support from the CIHR-funded Accelerating Clinical Trials (ACT) Consortium to establish a sustainable, pan-Canadian, distributive single REB review model. This model uses a network of qualified Canadian REBs and employs a process to select one REB of record to review each multi-site clinical trial under strict timelines.

This directed funding opportunity will provide interim support for the ongoing operation and expansion of the CanReview project to include as many jurisdictions as possible, while also continuing to evolve and adapt in order to work within a federated system, where needed.

Key Design Elements

The application from CanReview must incorporate all the following design elements:

• Features: The application must demonstrate how the streamlined ethics review process and its supporting structures incorporate, or have plans to incorporate, the following:
  • Formal mechanisms for participating institutions to delegate the REB review and oversight (including continuing review) to an REB of another institution.
  • Strict, internationally competitive timelines for submission, review, and communication.
  • An adaptable user-friendly platform that provides a single point of entry and communication for all participating sites, in both English and French, and can be adapted to offer interoperability with other information exchange platforms, to the extent this is possible, to enable participation of a maximal number of jurisdictions and institutions.
  • Compliance with all regulatory requirements, jurisdictional privacy laws, the TCPS and demonstrated leadership in implementing other applicable best practices.
  • Procedures and criteria for assessing the quality and consistency of participating REBs’ review processes, including their adherence to TCPS and its provisions for research involving Indigenous Peoples.
  • Procedures and criteria for establishing or assigning the REB of record for multi-site trials.
  • A workplan to build towards a fully pan-Canadian system that is flexible enough to include as many jurisdictions as possible and has mechanisms to work in a federated review model alongside other existing models in jurisdictions unable to fully participate due to constraints from existing legislation, policies or agreements.
  • Mechanisms to resolve substantive disagreements among participating REBs when more than one REB review is required due to participant protection or legal/regulatory/jurisdictional requirements.
• Governance: The project must be managed via a dedicated/standalone pan-Canadian and multi-sectorial governance and decision-making structure that includes high level representation from all involved jurisdictions, including federal government representatives, and key ecosystem partners (e.g., patient groups/communities, international experts, industry). The application must describe:
  • Roles and responsibilities of key players and governance structures.
  • Mechanisms for decision making, oversight, and dispute and conflict resolution.
  • Concrete strategies to ensure the governance upholds the principles of equity, diversity and inclusion (EDI), Indigenous rights, and patient / community engagement. This includes but is not limited to the engagement and inclusion of and diverse partners.
  • Participation of CIHR, in its oversight capacity, strictly as a non-voting ex officio observer on the highest governance committee, with no authority over operational approvals or decision making.
• Programming: The application must include a 30-month work plan, with key milestones, that outlines how the initiative will:
  • Continue developing and implementing a streamlined ethics review process that meets the requirements outlined in this funding opportunity.
  • Align processes and initiatives to achieve the greatest possible pan-Canadian reach.
  • Become fully sustainable by the end of the grant period, with no or minimal CIHR funding needed.
  • Include a plan for independent evaluation, consisting of a developmental evaluation within the first three months of funding and an independent formal evaluation—completed by the end of the grant—that will assess project progress, governance, and provide recommendations for continued evolution of this pan-Canadian initiative. NOTE: CIHR will establish a CIHR Oversight Committee that will monitor initiative progress, at the overall initiative level, against the milestones and objectives as outlined in the application for funding. This will include reviewing reports from CanReview, identifying any concerns with overall progress, and identifying potential linkages with other initiatives.

Role and Contributions of Applicant Partners

• CIHR recognizes that a broad range of partners may be relevant to this opportunity and it is expected that the applicant describes the role of all applicant partners and how/if they will contribute to the project. (see ) Any consideration of risk and/or conflict of interest must be explained, as appropriate. Funds Available

CIHR and partner(s) financial contributions are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or decrease due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to the grant received as a result of this funding opportunity.

• The total amount available for this funding opportunity is $5,000,000 over up to 30 months, enough to fund 1 grant.
• Funding beyond 15 months will be conditional and will depend on demonstrated need and the outcome of the CIHR Oversight process (see ). For more information on the appropriate use of funds, refer to .

---

Objectives

• The specific objective of this funding opportunity is to strengthen Canada’s clinical trial ecosystem and infrastructure, and position Canada as a competitive destination for global clinical trials by fostering the implementation of an efficient, high-quality, and sustainable research ethics review system for multi-site, multi-jurisdictional clinical trials in Canada, regardless of sponsor and source of funding, that:
  • Operates as a pan-Canadian system, accessible across all jurisdictions, subject to any local legislative or policy-related considerations; and
  • Is designed to avoid duplication of ethics reviews that are not anticipated to provide additional protections for research participants in accordance with TCPS; and
  • Provides for alternative approaches, as needed, through collaborative engagement, to establish a federated model that will work with the constraints of jurisdictional processes and legislation where applicable.

---

Eligibility

Eligibility to Apply

This is a directed grant towards the CanReview initiative.

For an application to be eligible, all the requirements stated below must be met:

1. The Nominated Principal Applicant (NPA) must be a confirmed CanReview and CTO Stream custodian.
2. The NPA must be appointed at an eligible institution (See List of CIHR Eligible Institutions Authorized to Administer Grant and Award Funds.
3. The NPA must have their substantive role in Canada for the duration of the requested grant term.
4. In addition to the NPA, the applicant team must include a minimum of 10 people across a minimum of 8 provinces or territories and who have the following expertise/experience/roles. One person may cover multiple perspectives, but all perspectives must be covered across the applicant team.
   • Expertise in the research ethics approval process with knowledge of research ethics governance structures.
   • Decision makers, such provincial/territorial health or research organizations, clinical trial enabling organizations, and policy makers.
   • (minimum of 2)
   • Individual(s) who can address the perspectives of Indigenous Peoples:
   • Individuals who self-identify as Indigenous (First Nations, Inuit or Métis) or provide evidence of having meaningful and culturally safe involvement with Indigenous Peoples, or both. These participants are required to submit an Indigenous Health Research Cultural Safety Form. See the section for more details; OR
   • ; OR
   • Indigenous non-governmental organizations. Note: Participants, including Elders and/or Indigenous Knowledge Holders, People with Lived/Living Experience (PWLE) may participate on an application in a Collaborator role without the need to secure a CIHR PIN. Follow the instructions in the section that pertain to Collaborators and indicate their role in the participant table. Elders' and/or Indigenous Knowledge Holders and People with Lived/Living Experience (PWLE)'s contributions to the proposed activities and their meaningful engagement must also be captured in the research proposal to address the points outlined in the evaluation criteria. Please note, names of Collaborators do not appear in CIHR funding decision databases and documents.

---

Guidelines

General CIHR Policies

Before submitting an application to this funding opportunity, applicants should review the relevant policies and guidelines on the CIHR Funding Policies page, including the CIHR Application Administration Guide – Part 2 General Requirements for Grants and Awards Applications, to ensure understanding of their roles and responsibilities.

CIHR’s position on EDI is available in the Tri Agency Statement on Equity, Diversity and Inclusion. Additional guidance can be found in the Best Practices in Equity, Diversity and Inclusion in Research. Beyond efforts to bolster EDI, CIHR recognizes that First Nations, Métis and Inuit are rights-holding as First Peoples of Canada and may not consider themselves to be part of equity-seeking groups. CIHR’s commitment to supporting Indigenous self-determination in health research is available in the CIHR Strategic Plan 2021–2031 and the Action Plan: Building a healthier future for First Nations, Inuit, and Métis peoples.

For information regarding principles of engagement, including approaches to compensation, refer to the SPOR Patient Engagement Framework.

Allowable Costs

Applicants are advised to consult the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Guide on Financial Administration (TAGFA) to determine if an expenditure is an appropriate use of grant funds.

Funds provided through this funding opportunity are restricted to supporting ecosystem strengthening and coordination functions only, and research projects are not eligible grant expenses.

To further clarify, the following expenses are examples of appropriate uses of grant funds, provided they satisfy the principles and pertinent directives of the TAGFA:

• Costs related to the mandatory developmental and final evaluations as outlined in the Key Design Elements - Programming section of this funding opportunity.
• Costs related to the adaptation of IT systems to offer interoperability, to the extent possible, with information exchange platforms of other participating jurisdictions
• Costs related to the translation and preparation of information/material intended for public consumption, including for the purposes of informing and engaging partners (website content, information pamphlets, guidelines, promotional and event-related material, etc.).
• Compensation of patient and community partners. See CIHR guidance on Considerations when paying patient partners. Use of Personal Information

All information is shared in accordance with the Privacy Act. As per the Privacy Act, personal information means information about an identifiable individual that is recorded in any form.

• Personal information submitted during the application process, including but not limited to information provided through applicant CVs, the Tri-agency Self-identification Questionnaire and other application documents required by this funding opportunity, will be made available to select CIHR personnel with the appropriate training and security clearance and on a need-to-know basis, for the purposes of future program planning and design and evaluation and learning for organizational and program strengthening. In addition, CIHR may share de-identified, aggregated self-identification information with the sponsoring institutes and competition partners, for this purpose. For further information about the Self-identification Questionnaire and the use of personal information, see the Tri-agency Self-identification Questionnaire Frequently Asked Questions.
• Personal information, including related research security forms, collected as part of the implementation of the research security measures, may be shared with Canada’s national security departments and agencies for the purpose of assessing risks to national security. Conditions of Funding

In addition to the general conditions of funding governing CIHR grants, the following are the program specific conditions of funding applicable to this funding opportunity:

• Data related to First Nations, Inuit or Métis communities whose traditional and ancestral territories are in Canada must be managed in accordance with data management principles developed and approved by those communities, and on the basis of free, prior and informed consent. This includes, but is not limited to, considerations of Indigenous data sovereignty, as well as data collection, ownership, protection, use, and sharing.
• All information intended for public consumption, including for the purposes of informing and engaging partners (e.g., website content, information pamphlets, guidelines, promotional and event-related material, etc.), must be provided in both official languages (English and French), accessible to screen readers, and should be developed using plain language practices. See . for more details.
• CIHR reserves the right to terminate or suspend funding if there is a determination of unacceptable national security risk by the Government of Canada.
• Given the objectives of this investment, CIHR may require additional information-sharing with decision-makers and participation in additional engagement activities.
• The Nominated Principal Applicant (NPA) will comply with and submit the following reporting and oversight process for this grant:
  • Complete an independent developmental evaluation. This evaluation must be completed within the first 3 months of the grant and submitted to CIHR with the Year 1 progress report as it will form part of the CIHR Oversight process.
  • Submit the Year 1 progress report to CIHR: The template and instructions for this report will be provided by CIHR within the first 3 months of the grant. The completed report must be submitted within two weeks of the one-year anniversary of the funding start date.
  • Participate in the CIHR led oversight process: The NPA, and other members of the leadership team as appropriate, must participate in CIHR’s Oversight process to review CanReview’s progress toward stated milestones and objectives, and to assess any potential risks at the overall initiative level.
  • Participation includes, but may not be limited to, responding to questions from the CIHR Oversight Committee in writing and/or attending a CIHR Oversight Committee discussion. The Oversight Committee will be created by CIHR for the purposes of monitoring the progress of the initiative but will not direct its activities.
  • The CIHR Oversight Committee will consider the Year 1 progress report and the results of the developmental evaluation to inform their discussion which will occur within 4 weeks of the report submission date.
  • Funding beyond the first 15 months of the grant is conditional and will depend on demonstrated need and the outcome of the CIHR Oversight process. The results will be provided to the NPA within six weeks of receipt of the Year 1 progress report.
  • Submit a final report: Templates and instructions will be made available to the NPA with the results of the CIHR oversight process. This report is due within 3 months of the end of the grant.
  • Complete a final independent formal evaluation by the end of the grant: This evaluation will assess project progress, governance, and provide recommendations for the continued evolution of this pan-Canadian initiative. The evaluation must be submitted to CIHR within 4 months of the end of the grant.
• As part of its oversight function, CIHR shall be included as an ex officio member on the highest level of the CanReview governance committee. CIHR role will be strictly as a non-voting observer with no authority over operational approvals or decision making.

---

Review Process and Evaluation

Review Process

For information on the peer review process for this funding opportunity, see the Review guidelines – Priority-driven initiatives - CIHR.

For information on CIHR’s peer review principles, see the Peer Review: Overview section of CIHR’s website.

Peer review will be conducted in accordance with the San Francisco Declaration on Research Assessment (DORA).

For this funding opportunity, an iterative peer review approach may be used. Applicants may be requested to provide additional information to support the application such as responding to comments from the peer review committee. The final funding recommendation will take into consideration the responses provided by the applicants. Further details regarding this process will be shared with the Nominated Principal Applicant after the application has been submitted.

Evaluation Criteria

To support the strategic objectives of this funding opportunity, the following evaluation criteria will be used:

1. Leadership and Governance
   1. Demonstration of an appropriate breadth of expertise and sector and jurisdictional authority within the leadership team, including research ethics, legal, health system decision-making, Indigenous health research, and capacity to deliver education and support that enhances ethics review efficiency.
   2. Appropriateness of the governance structure, with clear roles and responsibilities, balanced composition, inclusive leadership practices, appropriate and meaningful inclusion of PWLE and community members, transparent decision-making, and appropriate conflict resolution strategies.
   3. Extent to which the principles of EDI and Indigenous rights are integrated into team composition and governance processes (Refer to the Best practices in Equity, Diversity and Inclusion in Research for additional guidance).
   4. Demonstration of strong engagement with key health research decision makers across the Canadian research ethics ecosystem, supported by processes that draw on broad expertise and respect jurisdictional differences in legislation, policy, and local needs.
   5. Proactive and meaningful consideration of partnership risks, including the extent of real and/or perceived conflict of interest and appropriateness of its management and mitigation (if applicable).
2. Operational Framework
   1. Extent to which the proposed framework will standardize practices and operating procedures, supported by compliance with TCPS, privacy regulations, jurisdictional requirements, and other relevant best practices.
   2. Appropriateness of strategies to build trust between REBs, leverage existing models of streamlined ethics review, and coordinate with regional platforms to allow progression towards delegated acceptance of reviews.
   3. Extent to which the framework offers scalability and adaptability, including interoperability (to the extent possible) with other platforms, bilingual functionality, and flexibility to include all jurisdictions in Canada.
   4. Appropriateness of the plan to develop educational resources and training for researchers and for REB Chairs/Members, including to support socialization of standardized practices.
   5. Evidence of a user-friendly platform and operational plan that establishes strict, internationally competitive timelines for submission, review, and communication, and includes mechanisms for quality assurance, designation of REB of record, and resolution of substantive disagreements among REBs when more than one REB review is required.
3. Delivery and Impact
   1. Appropriateness and feasibility of the proposed work plan, including clarity of milestones and timelines for implementing the streamlined ethics review process and achieving pan-Canadian reach.
   2. Extent to which the plan demonstrates potential for measurable impact on efficiency (e.g., time to REB approval) and uptake by the research community.
   3. Quality and completeness of the planning to support the required independent developmental and formal evaluations that assess progress, governance, and provide recommendations for continued evolution of the initiative, including appropriate budgeting and resource planning to carry them out.
4. Budget
   1. Appropriateness of the proposed budget and justification for the amount requested.
   2. Feasibility of proposed activities based on available resources.
5. Financial Sustainability
   1. Strength of the proposed self-sustaining financial model, including the design and rationale of the user-fee structure and its capacity to support ongoing operational and future scaling costs with no or minimal reliance on external funding.
   2. Appropriateness of the financial projections in demonstrating a clear and achievable path to long-term sustainability. Funding Decision

One application will be accepted in response to this funding opportunity which will be funded provided it is in the fundable range.

The name of the funded applicant will be published on the CIHR website.

Partner and Internal Collaborator Participation

The opportunity to add new partners and internal collaborators to this funding opportunity may arise after publication. These partners and internal collaborators may not be listed; however, the principles that govern relevance review, including consent to share information and funding decisions, will still apply.

---

How to Apply

• The application process for this funding opportunity is comprised of one step: Full Application
• To complete your Full Application, follow the “Specific Instructions” listed below, and where applicable, consult the Grants – Application Guidelines.
  • Note: This funding opportunity is using the tri- agency CV.
• All participants listed, with the exception of Collaborators, are required to:
  • Have/obtain a CIHR PIN
  • Complete the Tri-Agency Self-identification Questionnaire.
• All documents must be in PDF format and must adhere to the guidelines for attachments on the Acceptable Application Formats and Attachments.
• Keep your information up to date: Regularly review and update your My CIHR Profile, including confirming the correct Primary Affiliation is linked.
  • The Primary Affiliation field of the My CIHR Profile is important for various funding related activities, including eligibility assessments and Research Support Fund calculations (if applicable). Your My CIHR Profile can be accessed by clicking on your name in the top right-hand corner of the ResearchNet screen. If your Primary Affiliation name is not available in the drop-down menu, contact the CIHR Contact Centre Specific instructions to complete and submit the application via ResearchNet.

Application

Task: Identify Participants

• List all participants in the “Identify Participants” task. Consult the section and ensure that all requirements are met.
• Only the Nominated Principal Applicant (NPA) is required to submit a tri-agency CV. As we gradually transition to the tri-agency CV, the system may continue to display references to the CCV. Please follow the tri-agency CV instructions as specified in the Funding Opportunity (FO) and complete and attach the tri-agency CV.
  • The maximum length of the CV is 5 pages in English and 6 pages in French. Any content in excess of the page limit set for the language will be removed without further notice to the NPA.
  • Submit the tri-agency CV by uploading the completed document in the “ Attachment ” tab and selecting “ Curriculum Vitae ” as the Document Type in the dropdown menu.
  • Consult the tri-agency CV instructions and the tri-agency CV – frequently asked questions for assistance with completing the tri-agency CV template

• All remaining team members on the application, in a role other than a Collaborator, are each required to provide a narrative description of how their expertise and experience support and complement the activities described in the Proposal. The information must be self-contained and include all relevant details.

  • The maximum length of the document per individual is 1 page.
  • The NPA is to submit the Team Member Expertise and Experience – Name for each team member by uploading the completed document in the “ Attachment ” tab and selecting “ Curriculum Vitae ” as the Document Type in the dropdown menu. Task: Enter Proposal Information

• The Proposal must outline each of the elements presented in the and describe how the initiative meets the and integrates all .

  • Proposals submitted to CIHR and written in French are permitted additional pages, in support of evidence demonstrating that French documents require approximately 20% more space than similar English documents. Therefore, to ensure an equitable amount of space is provided, the following page limits will apply:
  • Ten (10) pages if the proposal is written in English
  • Twelve (12) pages if the proposal is written in French Note: Any additional pages over the above-mentioned limit will be removed with no further notification to the Nominated Principal Applicant.

• References, charts, tables, figures and photographs can be uploaded under “Attachments – Research Proposal Appendix”.
  Task: Complete Summary of Proposal

• Summarize the proposal and describe how it will achieve the of this funding opportunity.

• Note that the summary cannot exceed one (1) page. The summary may be used to find reviewers with the expertise required to assess the Full Application.
  Task: Enter Budget Information

• Provide a detailed budget justification in relation to planned activities for all budget items.

• For information on budget items that can be included, please see the section.

• Note that CIHR seeks a recommendation from peer reviewers on the appropriateness of the budget and justification for the amount requested.
  Task: Attach Other Application Materials

• Attach the following under "Other":

  • Indigenous Experience (mandatory) – label as "Indigenous Experience - Name/Organization": the applicant team member who can address the perspectives of Indigenous Peoples either because they are Indigenous, including Elders and/or Knowledge Holders/Keepers, or can provide evidence of having meaningful and culturally safe involvement with Indigenous Peoples, or both, must also complete the Indigenous Health Research Cultural Safety Form [ PDF (646 KB) ], and their forms should be attached in this Attach Other Application Materials – Other section.
  • SGBA Training (mandatory) – label as "SGBA Training – Name": The Nominated Principal Applicant must have successfully completed one of the sex- and gender-based analysis training modules. Completion of SGBA training is optional for other participants. Attach the Certificate of Completion for the sex- and gender-based analysis training modules:
  • After completing the appropriate training module, you will receive a certificate of completion that you will save and upload here. The training module should take approximately 40 minutes to complete. Download the PDF Certificate and attach the PDF (or Print Screen jpg) here.
  • Applicant Partner COI Document (required if applicable) – Label as “Applicant Partner COI”: Describe the role of all applicant partners, how/if they will contribute to research and research related activities, and any consideration of risk and/or conflict of interest as appropriate (Maximum 1-page).
  • Participant Table (Mandatory) – upload under "Participant Table":
  • Download and complete this table which will be used for eligibility and peer review assessment. All team members must be listed and the information requested in the Participant Table provided. Task: Identify Application Partners (optional) – Upload Partner Information

• A "Partnership Details" form must be submitted for each partner providing cash and/or cash equivalent contributions.

• For each partner, upload a signed "Partner Letter" describing their role, activities, authorities, accountabilities and contributions (including intellectual, financial [cash or cash equivalent] and other resources).
  Task: Complete Peer Review Administration Information (Optional)

• This task collects information used for the purpose of peer review administration and aids CIHR in recruiting appropriate expertise.

• Applicants are encouraged to suggest Canadian and/or international reviewers that they think have the expertise to review their application. CIHR reserves the right to make the final selection of reviewers. You should not suggest reviewers in conflict of interest. Consult the Conflict of Interest and Confidentiality Agreement for Peer Reviewers and Peer Review Observers on the CIHR website for more information.
  Task: Manage Access (optional)

• The Nominated Principal Applicant (NPA) can delegate access to a maximum of five individuals to support the completion of the application. Note: A delegate’s access does not carry over from one stage of the competition to another (i.e., from the registration to the application stage). The NPA will need to delegate access at each stage of a competition. NPAs should revoke delegates’ access prior to completing the Consent and Submit tasks if they do not want them to retain access to submitted applications via their Completed Activities tab. For more information, please see the Frequently Asked Questions (FAQ).
  Task: Print Signature Page

• Signature Requirements:

  • Signature of the Nominated Principal Applicant is not required for applications submitted through ResearchNet.
  • Signatures must be included for all other applicants (except Collaborators), and individual(s) with signing authority from the Institution Paid.
  • Original signatures are not required. The scanned signed signature pages and the Routing Slip must be uploaded in the Print/Upload Signature Pages task in ResearchNet prior to submitting your application.

---

Contact Information

For all inquiries, please contact:

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178
Email: support-soutien@cihr-irsc.gc.ca

For service hours, please consult our CIHR Contact Centre page.

---

Sponsor Description

Partners

Internal Collaborators

Canadian Institutes of Health Research
At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada’s health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.

---

Additional Information

Definitions:

• Indigenous Knowledge Holder: A Knowledge Holder (also known as a Knowledge Keeper or Knowledge Guardian) is an Indigenous person, regardless of age, who possesses the Indigenous cultural knowledge necessary for the proposed research project or activities, as recognized, validated, and authenticated by the Indigenous community.
• Multi-sectoral: including key partners from such areas as academia, research hospitals, provincial and territorial clinical trial organizations, charities/not-for-profits, and private organizations/industry)
• A Person With Lived/Living Experience (PWLE): In the context of this funding opportunity, this includes individuals with personal experience of a health issue (patients), participation in clinical research, or navigating health systems. Relevant lived and living experience includes interactions with housing, education, justice or other systems that influence health. The term also includes caregivers (e.g., family and friends) and organizations representing PWLE.

• SGBA Plus: SGBA Plus refers to the consideration and examination of sex, gender, as well as additional intersecting identity factors (e.g., age, race, ethnicity, culture, religion, geography, education, disability, income and sexual orientation) and social processes (e.g., racism, ableism) at all stages of the research process including planning and implementation – please visit How to integrate sex and gender into research and Gender-based Analysis Plus (GBA Plus) for additional information.

• Search Again

• Back to Results

• Print Preview Opens in a new window

• Watch this Opportunity

• Notify a Colleague
  Date Modified:

20260226.1